Current Events

The iMedicine & Mobile Life Sciences World Summit provides a unique opportunity for mHealth developers to showcase and present their new technologies to a global eHealth audience; and for healthcare practitioners and pharmaceutical executives to present case studies on clinical or medical educational needs or outcomes of App implementation to highlight progress, challenges, and opportunities in the highly dynamic digital age.

Bio-IT World Asia 2012 will bring together, life sciences, pharmaceutical, informatics and IT professionals from all over Asia and the rest of the world to one unique location. The Event provides the perfect venue to share information and discuss enabling technologies that are driving biomedical research and the drug development process. This year’s event will include dedicated tracks that include: IT Infrastructure and the Cloud Drug Discovery Informatics Bioinformatics NGS Data Management and Interpretation

Given the crisis facing the pharmaceutical industry in the translation of early stage drug discovery results, a different set of tools, concerned with algorithms and methods for developing best in class drugs that engage biological targets with kinetically optimized potency and selectivity will need to be refined. In this conference, we bring to focus recent advancements in this field from an experienced faculty. Keynote Address: Binding Kinetics in Drug Discovery David Swinney, Ph.D., CEO, Institute for Rare and Neglected Diseases Drug Discovery (iRND3)

The 76th Prague Meetings on Macromolecules: Polymers in Medicine will focus on the latest innovative development in drug delivery systems. Meeting brings together multi-disciplinary researchers from both academia and industry in the areas of pharmaceutics, polymer and materials science, imaging, cell and molecular biology, genetic, and medicine.

Whether you are developing a brand new process or optimizing an existing synthetic route, the aims are always the same: • Achieving greater process efficiency, yield and throughput. • Eliminating unsafe and non-green processes and materials. • Decreasing the costs and number of steps involved. Since the first conference in 1994, The Scale-Up of Chemical Processes has become the major international forum for the discussion of all these aspects of scale-up and more in the pharmaceutical, fine chemical and allied fields. Key speakers will present case studies and examples of some of the pitfalls and problems they encountered and how they overcame them. With unparalleled networking opportunities, this broad-based conference is the best place to learn about and discuss the latest novel ideas and techniques with the key people in the industry.

Conference topics Chemical modification, degradation, biodegradation, ageing, stabilization, fire retardancy, recycling and reuse of bulk polymers, polymer blends, filled systems and polymer coatings.

Personalized medicine has the potential to revolutionize medical care by utilizing an improved understanding of genetics and molecular biology to allow for better diagnostic tests, more precise diagnoses, greater predictability of disease course, and improved patient safety by selecting not only the right drug for a patient but also the proper dosage to reduce adverse effects. Speakers and panelists will answer the following key questions: *What types of challenges need to be met in order to realize the true commercial potential of personalized medicine? *Will insurers fund the genomic revolution? *What types of validation requirements are they looking for? *What will be their criteria for reimbursement? *What are the real-world challenges to successful adoption of molecular/companion diagnostics? *Who needs to partner in order to advance the field of personalized medicine? *What are the goals, utility and challenges associated with Rx-Dx partnerships? *How and when are relationships being initiated today? *How are companies navigating their way through the world's regulatory bodies? *What kind of impact are Pharmacy Benefit Managers (PBMs) and for that matter new genetic testing benefit managers going to have on the future of personalized medicine? *What types of efforts are being made to influence adoption via physician education?

The efficient conversion of a chemical process into a process for manufacture on tonnage scale has always been of importance in the chemical and pharmaceutical industries. However, in the current economic and regulatory climate, it has become increasingly vital and challenging to do so efficiently. At our Organic Process Research & Development Conference, you will hear detailed presentations and case studies from top international chemists. Our hand-picked programme of speakers has been put together specifically for an industrial audience. They will discuss the latest issues relating to synthetic route design, development and optimisation in the pharmaceutical, fine chemical and allied fields. Unlike other conferences, practically all our speakers are experts from industry, which means the ideas and information you take home will be directly applicable to your own work.

The 7th annual Pharma-Bio-Med & BioSciences Information and CI Conference & Exposition is the premier event in Europe that is tailored to the interests of information, library, knowledge management and informatics practitioners working with competitor intelligence and bioscience data information in industries such as pharma and biotech, food, nutrition, agriculture/crop science cosmetics, diagnostics and devices, academic and government health sciences fields.

The international meeting of scientists to share recent developments, exchange ideas, explore new directions and initiate a possible collaboration in the atomic spectrometry area and in other spectroscopy techniques. Leading scientists and researchers will be invited to present their most up-to-date results on this conference, to exchange exciting ideas and experiences as well as look into future development.

Hype or reality? Much has been made of developments in catalysis in synthetic organic chemistry. This Scientific Update event aims to bring together industrial chemists and academics to learn about emerging catalytic methods and their industrial application. Featuring top speakers from academia and industry, this event will provide industrial chemists with an unparalleled opportunity to explore how catalysis is beginning to change the landscape of process chemistry. How will this conference help you? This conference will attract an international audience of around 100-150 delegates and is intended for senior chemists and technical managers from the Pharmaceutical, Fine and Speciality Chemical, Agrochemical, Flavour, Fragrance and Colour Chemical industries. A detailed, high-quality book of conference proceedings covering all the presentations is provided and there will be ample opportunity for questions and stimulating discussion during the conference.

Although production of new polymorphs and solvates can be a source of profit for companies through extension of the patent lifetime, the inability to manufacture a consistent crystalline form often leads to costly project delays, particularly in chemical development. This conference will focus on these issues from the viewpoint of the process chemist and chemical engineer; i.e. on chemical development issues which impact the ability to routinely manufacture the chosen crystalline form, whether this be the most stable or a metastable crystal. Case studies from different companies will show how different organisations identify and solve these extremely difficult issues in different ways, depending on how far the project is along the development time line. Experts in the field will also give lectures on problem solving and troubleshooting, as well as giving insight into new techniques, (supercritical fluids, polymorph prediction etc.) which will be of value in the future.

We are pleased to announce XX International Conference on Chemical Reactors "CHEMREACTOR-20" to be held in December 3-7, 2012 in Luxemburg